Please login to the form below

AndroGel

This page shows the latest AndroGel news and features for those working in and with pharma, biotech and healthcare.

AbbVie sales jump on strong Humira gains

Among other products, HIV therapy Kaletra (lopinavir/ ritonavir) rose 1.1 per cent to $278m, while revenue from testosterone replacement therapy AndroGel fell 6.5 per cent to $258m.

Latest news

Pay-for-delay deals 'sometimes violate antitrust law'

involving testosterone replacement therapy product AndroGel should be allowed to go forward.
AbbVie expects Humira to drive growth in inaugural guidance

Top of the list in the speciality division is testosterone replacement therapy AndroGel – 31 per cent to $1.15bn in 2012 – with support from Creon (pancrelipase) for pancreatic insufficiency and hypothyroidism
Abbott restructuring drags down Q2 profits

arthritis treatment Humira (adalimumab), which was up 16.5 per cent $2.33bn, and testosterone gel Androgel, which grew 24.7 per cent to $276m.
Abbott plans Solvay layoffs

Solvay's product portfolio includes the testosterone gel AndroGel, the progesterone capsule Prometrium, and the pancreatic enzyme replacement therapy Creon (pancreatin).

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Pharma deals in May 2015

This is not the first such case for Teva, as the FTC also filed suit last September for an alleged pay for delay relating to AndroGel.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editor – Medical Education Agency – Bucks: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Account Manager – Med Comms – London: Salary TBC

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Account Manager or AD - Medical Communications: Salary TBC

Scientific Director: Great salary and bebefits

Senior Account Manager / Account Director: Great salary and bebefits

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Medical Writer: Great salary and benefits

Editorial Director – Medical Education – Oxford: Negotiable

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior Programme Executive: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Senior Medical Writer: Great salary and bebefits

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

No incentive for a cure: The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...